Shanghai Pharmaceuticals Holding (601607.SH): Digoxin Tablets pass the evaluation of generic drug consistency.

Shanghai Pharmaceuticals Holding (601607.SH) announced that recently, its subsidiary Shanghai Shangyao Xinyi Pharmaceutical Factory Co., Ltd., also known as "Shangyao Xinyi," received the "Drug Supplement Application Approval Notice" (Notice No.: 2026B01912) issued by the National Medical Products Administration. The drug digoxin tablet has passed the generic drug consistency evaluation. Digoxin tablets are used for: 1. treating mild to moderate heart failure in adults. Digoxin can increase left ventricular ejection fraction and improve symptoms of heart failure, leading to improved exercise capacity and reduced heart failure-related hospitalizations and emergency treatments, with no impact on mortality. Digoxin should be used in combination with diuretics and angiotensin-converting enzyme (ACE) inhibitors whenever possible. 2. Increasing myocardial contractility in pediatric heart failure patients. 3. Controlling ventricular rate in patients with atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia with rapid ventricular rates.